Current efforts are heavily directed towards the development of effective and stable solid oral dosage forms and compounding in general.
My research has included studies on the interaction of drugs with plasma proteins and methods for examining such interactions. Another area of interest is improvement in aqueous drug solubility and, therefore, bioavailability, through complexation of drug with cyclodextrans.
